Daniel M. Altmann, PhD

Professor Altmann is Professor of Immunology at Imperial College London, where he heads a lab at the Hammersmith Hospital Campus. Professor Altmann has acted in a range of roles during the pandemic in advice to policymakers, including the House of Commons and House of Lords Science Committees., Layla Moran MP’s APPG on Long Covid, advice to the Cabinet Office, to Sir Keir Starmer and the Shadow Cabinet, the Welsh Assembly, the EU,  The Scottish Parliament, WHO, NICE and the Department of Health. He has served for over 20 years as Editor across medical journals including Oxford Open Immunology, Immunology, and Vaccine. He is a trustee at the Medical Research Foundation as well as Long Covid Support and a board member for the African Research Excellence Fund. He previously headed up strategy on infection, immunity and population health at the Wellcome Trust.  Professor Altmann’s research interests focus on the immunology of infectious diseases including severe bacterial infections, SARS-CoV-2, Zika virus and Chikungunya virus, as well as a long record in autoimmunity research. His SARS-CoV-2 research is published in journals including the Lancet, Nature and Science. He is currently heading an NIHR-funded research programme to look at mechanisms of pathogenesis and development of new diagnostic tests in a large cohort of individuals with Long Covid.